Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Fort Lee, NJ, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Pharmaceutical
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics), a biopharmaceutical company committed...
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO...
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
PRINCETON, NJ / ACCESSWIRE / August 31, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Ultragenyx to Participate at Investor Conferences in September
Citi BioPharma Conference on September 6 in Boston Morgan Stanley Healthcare Conference on September 12 in New York City NOVATO,...
Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer
Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inhibitor BMF-219...
IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)
SAINT LAURENT, Quebec, Aug. 31, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”) announces the...
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing...
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
Pleasanton, CA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a...
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics
Acer Therapeutics buys Relief Therapeutics' stake in OLPRUVA™ worldwide, excluding geographical Europe, providing an upfront payment of $10 million in...
Spencer Health Solutions Raises Series D to Expand Pharmaceutical and Care Management Markets
MORRISVILLE, N.C.--(BUSINESS WIRE)--Spencer Health Solutions, Inc., a pharma services and health technology company, announced today the successful close of its...
Interim report January – June 2023
STOCKHOLM, SE / ACCESSWIRE / August 30, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0)April to JuneNet sales amounted to MSEK 0.1 (0)Net...
VitalPointTech Announces Acquisition of Herban Healing, LLC, a Revolutionary Bio-Pharmaceutical Company
Herban Healing is dedicated to providing alternative healthcare options to combat the opioid crisisHOUSTON, TX / ACCESSWIRE / August 29,...
Nova Mentis Announces Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
Pressure BioSciences Provides Second Progress Report on UltraShear Nano-CBD Launch and Commercialization Program “Drive to 420!”
Additional Five Customers Committed to Distributing PBIO's Best-in-Class UltraShear Nano-CBD, Representing Nearly 350 Retailers and Over $200K Incremental 2023 SalesSOUTH...
The Science Times Publishes Article About Jaguar Health’s Focus on Developing Crofelemer for Two Rare Disease Indications
Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion...
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador
AI Tape has potential to tap into the $236 million Elastic Therapeutic Tape marketORLANDO, FL / ACCESSWIRE / August 30,...
Moderna to Host Investor Event – R&D Day and Business Updates
CAMBRIDGE, MA / ACCESSWIRE / August 30, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor...
Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023
MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023
Additional biomarker data up to two years of treatment continue to demonstrate rapid and sustained normalization of CSF heparan sulfate...